ID: h-var-5bc88e4dd8
Hypothesis

TFEB Family Multi-Target Activation for Synaptic Lysosomal Restoration in Alzheimer's Disease

This hypothesis proposes that coordinated activation of the entire TFEB family (TFEB, TFE3, TFE4) creates synergistic enhancement of lysosomal biogenesis specifically at synaptic terminals in Alzheimer's disease.
🧬 TFEB/TFE3/TFE4🩺 proteomics🎯 Composite 38%💱 $0.46▲15.1%proposed
EvidencePending (0%)📖 0 cit🗣 1 debates 6 support 6 oppose
✓ All Quality Gates Passed

🧪 Overview

This hypothesis proposes that coordinated activation of the entire TFEB family (TFEB, TFE3, TFE4) creates synergistic enhancement of lysosomal biogenesis specifically at synaptic terminals in Alzheimer's disease. While previous approaches focused on single-target TFEB activation, the multi-target family approach leverages the distinct but overlapping transcriptional programs of TFE3 and TFE4, which show preferential expression in different neuronal subtypes and subcellular compartments. TFE3 exhibits enhanced synaptic localization and directly regulates presynaptic autophagy machinery, while TFE4 controls postsynaptic lysosomal positioning and cargo recognition. Simultaneous activation of all three family members through dual mTORC1/GSK3β inhibition will create complementary waves of lysosomal gene expression, targeting different aspects of the autophagy-lysosomal cascade. This coordinated response will establish robust clearance of amyloid-beta oligomers from synaptic clefts and tau aggregates from dendritic spines, addressing both presynaptic and postsynaptic pathology.

...

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["mTORC1 Hyperactivation<br/>Nutrient/Growth Signals"]
    B["TFEB Phosphorylation<br/>Ser211 by mTORC1"]
    C["14-3-3 Sequestration<br/>Cytoplasmic Retention"]
    D["Lysosomal Biogenesis<br/>Blocked"]
    E["Autophagic Flux<br/>Impaired"]
    F["Tau/Amyloid Aggregate<br/>Accumulation"]
    G["TFEB Activation<br/>Rapamycin or MCOLN1"]
    H["Nuclear TFEB<br/>CLEAR Gene Expression"]
    G --> H
    H -.->|"rescues"| D
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style F fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style G fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style H fill:#1b5e20,stroke:#81c784,color:#81c784

⚖️ Evidence

⚖️ Evidence Matrix6 supports6 contradicts
Supports
TFEB overexpression reduces tau aggregation and Aβ toxicity in cellular models
Supports
Impaired TFEB nuclear localization observed in AD brain tissue with mTOR hyperactivation
Supports
Trehalose enhances lysosomal biogenesis and reduces protein aggregates in neurodegeneration models
Supports
Autophagosome accumulation in AD synapses indicates upstream autophagy initiation is intact but downstream lysosomal degradation is blocked
Supports
mTOR inhibitors (rapamycin analogs) enable TFEB nuclear translocation
Supports
TFEB activation bypasses upstream mTOR dysregulation and directly enhances lysosomal gene expression
Contradicts
TFEB regulates hundreds of genes beyond lysosomal biogenesis including lipid metabolism and inflammatory pathways
Contradicts
TFEB overexpression paradoxically increases neurodegeneration in α-synuclein models via APP-like substrate processing
Contradicts
Global TFEB activation in microglia exacerbates neuroinflammation through enhanced lysosomal antigen presentation
Contradicts
TFEB haploinsufficiency is protective in certain aging paradigms, suggesting a 'Goldilocks' principle
Contradicts
Trehalose acts as chemical chaperone independently of TFEB
Contradicts
Genistein is a broad kinase inhibitor with estrogenic activity
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — TFEB

No curated PDB or AlphaFold mapping for TFEB yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for TFEB/TFE3/TFE4 from GTEx v10.

Spinal cord cervical c-127.0 Cerebellum11.3median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for TFEB →

No DepMap CRISPR Chronos data found for TFEB.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0026
Events (7d)
1
Price History
▲15.1%

💾 Resource Usage

LLM Tokens
39,448
$0.1183
Total Cost
$0.1183
Metadatasource: v1_phase_c_backfill · origin_type: gap_debate
sourcev1_phase_c_backfill
origin_typegap_debate
_schema_version1
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.